Literature DB >> 19638456

Tumor endothelial cells join the resistance.

Andrew C Dudley1, Michael Klagsbrun.   

Abstract

The field of antiangiogenesis research has been met with some surprises, including the realization that tumor blood vessels are more complex and labile than expected. In this issue of Clinical Cancer Research, Xiong and colleagues show that tumor-specific endothelial cells are less sensitive to cytotoxic and antiangiogenic drugs compared to their normal counterparts.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19638456      PMCID： PMC2729656          DOI： 10.1158/1078-0432.CCR-09-0902

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  13 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

2.  A very effective treatment for neovascular macular degeneration.

Authors:  Edwin M Stone
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

3.  Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.

Authors:  Reginald Hill; Yurong Song; Robert D Cardiff; Terry Van Dyke
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

Review 4.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Altered angiogenesis and survival in human tumor-derived endothelial cells.

Authors:  Benedetta Bussolati; Ilaria Deambrosis; Simona Russo; Maria Chiara Deregibus; Giovanni Camussi
Journal:  FASEB J       Date:  2003-04-22       Impact factor: 5.191

6.  Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.

Authors:  Yu-Quan Xiong; Hui-Chuan Sun; Wei Zhang; Xiao-Dong Zhu; Peng-Yuan Zhuang; Ju-Bo Zhang; Lu Wang; Wei-Zhong Wu; Lun-Xiu Qin; Zhao-You Tang
Journal:  Clin Cancer Res       Date:  2009-07-28       Impact factor: 12.531

Review 7.  Angiogenesis: an organizing principle for drug discovery?

Authors:  Judah Folkman
Journal:  Nat Rev Drug Discov       Date:  2007-04       Impact factor: 84.694

Review 8.  Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.

Authors:  Lee M Ellis; Daniel J Hicklin
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

Review 9.  Modes of resistance to anti-angiogenic therapy.

Authors:  Gabriele Bergers; Douglas Hanahan
Journal:  Nat Rev Cancer       Date:  2008-08       Impact factor: 60.716

10.  Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine.

Authors:  A C Dudley; S-C Shih; A R Cliffe; K Hida; M Klagsbrun
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640
View more
  5 in total

Review 1.  Role of liver stem cells in hepatocarcinogenesis.

Authors:  Lei-Bo Xu; Chao Liu
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

2.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

Review 3.  Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.

Authors:  Justin N Bottsford-Miller; Robert L Coleman; Anil K Sood
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

4.  Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy.

Authors:  Limin Huang; Christelle Perrault; Jennifer Coelho-Martins; Chaoquan Hu; Charlène Dulong; Mariana Varna; Jielin Liu; Jian Jin; Claudine Soria; Lionel Cazin; Anne Janin; Hong Li; Rémi Varin; He Lu
Journal:  J Hematol Oncol       Date:  2013-07-09       Impact factor: 17.388

5.  Glucose-regulated protein 78 (Grp78) confers chemoresistance to tumor endothelial cells under acidic stress.

Authors:  Fernanda Visioli; Yugang Wang; Goleeta N Alam; Yu Ning; Pantelis V Rados; Jacques E Nör; Peter J Polverini
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.